Advertisement

Drugs

, Volume 56, Issue 2, pp 250–250 | Cite as

Orlistat

A Viewpoint by Madeleine L. Drent
  • Madeleine L. Drent
Adis New Drug Profile Guest Commentary

References

  1. 1.
    Drent ML, van der Veen EA. Lipase inhibition: a novel concept in the treatment of obesity. Int J Obes 1993; 17: 241–4Google Scholar
  2. 2.
    Drent ML, Larsson I, William-Olsson T, Quaade F, et al. Orlistat (RO 18-0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study. Int J Obes 1995;19: 221–6Google Scholar

Copyright information

© Adis International Limited 1998

Authors and Affiliations

  • Madeleine L. Drent
    • 1
  1. 1.Department of EndocrinologyFree University HospitalHV AmsterdamThe Netherlands

Personalised recommendations